Alumis (ALMS) News Today $4.61 +0.17 (+3.83%) Closing price 04:00 PM EasternExtended Trading$4.62 +0.01 (+0.33%) As of 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALMS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Alumis (NASDAQ:ALMS) Earns Sell (E+) Rating from Weiss RatingsOctober 8, 2025 | marketbeat.comBrokerages Set Alumis Inc. (NASDAQ:ALMS) PT at $20.17October 5, 2025 | americanbankingnews.comAlumis Inc. (NASDAQ:ALMS) Receives Average Recommendation of "Buy" from AnalystsOctober 2, 2025 | marketbeat.comPositive Signs As Multiple Insiders Buy Alumis StockSeptember 26, 2025 | finance.yahoo.comAlumis Inc. (ALMS) Presents at Stifel Virtual Immunology and Inflammation Forum TranscriptSeptember 17, 2025 | seekingalpha.comAlumis Inc. (NASDAQ:ALMS) Receives Average Rating of "Buy" from AnalystsSeptember 8, 2025 | marketbeat.comAlumis Inc. Updates Corporate Presentation on PipelineSeptember 3, 2025 | tipranks.comAlumis to Participate in Upcoming September Investor ConferencesAugust 29, 2025 | globenewswire.comHC Wainwright Comments on Alumis' Q3 Earnings (NASDAQ:ALMS)August 19, 2025 | marketbeat.comEquities Analysts Set Expectations for Alumis Q3 EarningsAugust 19, 2025 | marketbeat.comAlumis Inc. Reports Q2 2025 Earnings and Strategic AdvancesAugust 18, 2025 | tipranks.comAlumis (NASDAQ:ALMS) Given New $22.00 Price Target at Morgan StanleyAugust 17, 2025 | marketbeat.comAlumis (NASDAQ:ALMS) Stock Rating Upgraded by Wall Street ZenAugust 17, 2025 | marketbeat.comAnalysts’ Opinions Are Mixed on These Materials Stocks: Alumis Inc. (ALMS) and Mosaic Co (MOS)August 16, 2025 | theglobeandmail.comAlumis Inc. Beat Analyst Profit Forecasts, And Analysts Have New EstimatesAugust 16, 2025 | finance.yahoo.comAlumis' (ALMS) "Buy" Rating Reiterated at HC WainwrightAugust 16, 2025 | marketbeat.comAlumis (NASDAQ:ALMS) Announces Earnings ResultsAugust 15, 2025 | marketbeat.comAlumis Inc. (NASDAQ:ALMS) Given Average Recommendation of "Buy" by BrokeragesAugust 14, 2025 | marketbeat.comAlumis Reports Second Quarter 2025 Financial Results and Provides Corporate UpdateAugust 13, 2025 | globenewswire.comWhile institutions invested in Alumis Inc. (NASDAQ:ALMS) benefited from last week's 4.1% gain, individual investors stood to gain the mostAugust 10, 2025 | finance.yahoo.comAlumis Inc. Concludes 2025 Annual Stockholders MeetingAugust 8, 2025 | theglobeandmail.comAlumis (ALMS) to Release Quarterly Earnings on TuesdayAugust 6, 2025 | marketbeat.comAlumis (ALMS) Merges with ACELYRINJuly 29, 2025 | msn.comAlumis (NASDAQ:ALMS) Coverage Initiated by Analysts at Wells Fargo & CompanyJuly 26, 2025 | marketbeat.comAlumis (NASDAQ:ALMS) Given "Buy" Rating at HC WainwrightJuly 26, 2025 | marketbeat.comWells Fargo Initiates Coverage of Alumis (ALMS) with Overweight RecommendationJuly 26, 2025 | msn.comAlumis Inc. Completes Patient Enrollment in LUMUS Phase 2b Trial of ESK-001 for Systemic Lupus Erythematosus, Topline Data Expected Q3 2026July 24, 2025 | quiverquant.comQAlumis Completes Patient Enrollment in the Global LUMUS Phase 2b Trial of ESK-001, a Next-Generation Oral TYK2 Inhibitor for the Treatment of Systemic Lupus ErythematosusJuly 24, 2025 | globenewswire.comAlumis Inc. (NASDAQ:ALMS) Receives Consensus Recommendation of "Buy" from BrokeragesJuly 19, 2025 | marketbeat.comAlumis (NASDAQ:ALMS) Stock Price Up 2% - Here's What HappenedJuly 18, 2025 | marketbeat.comAlumis Announces the Promotion of Sanam Pangali to Chief Legal Officer and Corporate SecretaryJuly 14, 2025 | globenewswire.comFY2025 EPS Estimates for Alumis Lowered by Cantor FitzgeraldJune 19, 2025 | marketbeat.comAlumis (ALMS) Projected to Post Quarterly Earnings on WednesdayJune 11, 2025 | marketbeat.comCantor Fitzgerald Estimates Alumis FY2026 EarningsJune 10, 2025 | marketbeat.comAlumis (NASDAQ:ALMS) Coverage Initiated by Analysts at GuggenheimJune 10, 2025 | marketbeat.comAlumis Target of Unusually Large Options Trading (NASDAQ:ALMS)June 4, 2025 | marketbeat.comAlumis Inc.: Alumis Completes Enrollment of Pivotal Phase 3 ONWARD Clinical Program of Lead Candidate ESK-001, a Highly Selective, Next-Generation Oral TYK2 Inhibitor for the ...May 31, 2025 | finanznachrichten.deAlumis Completes Enrollment of Pivotal Phase 3 ONWARD Clinical Program of Lead Candidate ESK-001, a Highly Selective, Next-Generation Oral TYK2 Inhibitor for the Treatment of ...May 31, 2025 | seekingalpha.comAlumis Inc. (NASDAQ:ALMS) Given Consensus Rating of "Buy" by AnalystsMay 31, 2025 | marketbeat.comAnalysts' Revenue Estimates For Alumis Inc. (NASDAQ:ALMS) Are Surging HigherMay 29, 2025 | finance.yahoo.comAlumis to Present at the Jefferies Global Healthcare Investor ConferenceMay 29, 2025 | globenewswire.comAlumis Completes Enrollment of Pivotal Phase 3 ONWARD Clinical Program of Lead Candidate ESK-001, a Highly Selective, Next-Generation Oral TYK2 Inhibitor for the Treatment of Moderate-to-Severe Plaque PsoriasisMay 29, 2025 | globenewswire.comFY2026 Earnings Forecast for Alumis Issued By HC WainwrightMay 27, 2025 | marketbeat.comAlumis completes merger with ACELYRIN, extends cash runwayMay 22, 2025 | uk.investing.comAlumis Inc. Completes Merger with ACELYRIN, Inc.May 21, 2025 | tipranks.comAlumis Completes Merger with ACELYRINMay 21, 2025 | globenewswire.comAlumis Inc. (NASDAQ:ALMS) Shares Bought by Tang Capital Management LLCMay 20, 2025 | marketbeat.comAlumis Inc. Reports Q1 2025 Financial Results and Strategic ProgressMay 15, 2025 | tipranks.comACELYRIN, Inc. Stockholders Approve Merger Agreement with Alumis Inc.May 15, 2025 | nasdaq.comACELYRIN shareholders approve Alumis merger dealMay 15, 2025 | uk.investing.com Get Alumis News Delivered to You Automatically Sign up to receive the latest news and ratings for ALMS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ALMS Media Mentions By Week ALMS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALMS News Sentiment▼0.830.75▲Average Medical News Sentiment ALMS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALMS Articles This Week▼34▲ALMS Articles Average Week Get the Latest News and Ratings for ALMS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Alumis and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies GPCR News BHVN News STOK News ABCL News IMCR News VCEL News JANX News EWTX News RCUS News HRMY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALMS) was last updated on 10/13/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alumis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alumis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
